These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32164876)

  • 1. Adjuvant
    Vogel A; Saborowski A
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):517-519. PubMed ID: 32164876
    [No Abstract]   [Full Text] [Related]  

  • 2. A meta-analysis of the efficacy and safety of iodine [
    Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Bian H; Zheng JS; Nan G; Li R; Chen C; Hu CX; Zhang Y; Sun B; Wang XL; Cui SC; Wu J; Xu J; Wei D; Zhang X; Liu H; Yang W; Ding Y; Li J; Chen ZN
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25210200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
    Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
    Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
    Chen ZN; Mi L; Xu J; Song F; Zhang Q; Zhang Z; Xing JL; Bian HJ; Jiang JL; Wang XH; Shang P; Qian AR; Zhang SH; Li L; Li Y; Feng Q; Yu XL; Feng Y; Yang XM; Tian R; Wu ZB; Leng N; Mo TS; Kuang AR; Tan TZ; Li YC; Liang DR; Lu WS; Miao J; Xu GH; Zhang ZH; Nan KJ; Han J; Liu QG; Zhang HX; Zhu P
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):435-44. PubMed ID: 16690431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial iodine-131-labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 patients.
    Wu L; Yang YF; Ge NJ; Shen SQ; Liang J; Wang Y; Zhou WP; Shen F; Wu MC
    Cancer Biother Radiopharm; 2010 Dec; 25(6):657-63. PubMed ID: 21204759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I-Labeled-Metuximab Plus Transarterial Chemoembolization in Combination Therapy for Unresectable Hepatocellular Carcinoma: Results from a Multicenter Phase IV Clinical Study.
    Ma J; Wang JH
    Asian Pac J Cancer Prev; 2015; 16(17):7441-7. PubMed ID: 26625741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Arterial Chemoembolization Plus
    Zhu ZX; Liao MH; Wang XX; Huang JW
    Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
    Tabone M; Vigano L; Laudi C; Ferrero A; Pellerito R; Capussotti L
    Hepatology; 2005 Jun; 41(6):1433; author reply 1433-4. PubMed ID: 15834934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radioimmunoimaging of hepatocellular carcinoma with 131I labeled antihepatoma monoclonal antibody Fab fragment].
    Sui Y; He F; Chen Z
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):537-9. PubMed ID: 10923467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunodetection and autoradiographic localization of monoclonal antibody against human hepatocellular carcinoma in xenografts.
    Ji YY; Liu YF; Chen ZN
    Cancer; 1992 Apr; 69(8):2055-9. PubMed ID: 1311979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and treatment planning in radioimmunotherapy.
    Leichner PK; Yang NC; Wessels BW; Hawkins WG; Order SE; Klein JL
    Front Radiat Ther Oncol; 1990; 24():109-20; discussion 121-2. PubMed ID: 2160407
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunolocation of metastases from adenocarcinoma of the colon: using a hepatoma antibody.
    Divgi CR; Cohen AM
    Hepatology; 1990 May; 11(5):891-2. PubMed ID: 2161398
    [No Abstract]   [Full Text] [Related]  

  • 14. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
    Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
    J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
    [No Abstract]   [Full Text] [Related]  

  • 15. I
    Wu L; Sun B; Lin X; Liu C; Qian H; Chen L; Yang Y; Shen F; Su C
    Genes Cells; 2018 Jan; 23(1):35-45. PubMed ID: 29210217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
    Launois B; Maddern G
    Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal anti-AFP immunoscintigraphy of human hepatocellular carcinoma. Influence of biological, anatomical and vascular factors].
    Duclos B; Demangeat JL; Manil L; Chamouard P; Baumann R; Demangeat C; Bruno B; Jaeck D; Constantinesco A; Weill JP
    Gastroenterol Clin Biol; 1989 Nov; 13(11):910-5. PubMed ID: 2482215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
    Raoul JL; Boucher E; Roland V; Garin E
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy.
    Bergmann JF; Lumbroso JD; Manil L; Saccavini JC; Rougier P; Assicot M; Mathieu A; Bellet D; Bohuon C
    Eur J Nucl Med; 1987; 13(8):385-90. PubMed ID: 2449350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.